« Antibiotic Use Decreasing | Main | Resistance To Antiviral and Antibacterial Agents »

Vancomycin Dosing for Staph Aureus

Dosing and monitoring recommendations for Vancomycin in the treatment of Staph Aureus infections have been modified due to rising minimum inhibitory concentrations (MIC) nationwide. For more information, see the August 1 issue of Clinical Infectious Diseases (Clin Infect Dis. 2009;49:325–327). For those with Medscape access, click here to veiw a summary of the recommendations.

Posted on Friday, July 24, 2009 at 02:55PM by Registered CommenterAdministrator | CommentsPost a Comment

PrintView Printer Friendly Version

EmailEmail Article to Friend

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

PostPost a New Comment

Enter your information below to add a new comment.
Author Email (optional):
Author URL (optional):
All HTML will be escaped. Hyperlinks will be created for URLs automatically.